Breaking News Bar

Business News and Information

Editas Medicine to Host Conference Call Discussing Third Quarter 2020 Results and Corporate Update

CAMBRIDGE, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Thursday, November 5, 2020, at 5:00 p.m. ET to discuss a corporate update and results for the third quarter of 2020.

Conference Call & Webcast Details 
Date:Thursday, November 5, 2020
Time:5:00 pm Eastern Time
Toll Free:(844) 348-3801
International:(213) 358-0955
Conference ID:9992536

A live webcast of the conference call can be accessed in the Investors section of Editas Medicine website at

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit

Mark Mullikin
(617) 401-9083 

Cristi Barnett
(617) 401-0113 

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear